MicuRx Pharmaceuticals, Inc. ('MicuRx'), a clinical-stage biopharmaceutical company focused on developing novel anti-infective therapies for drug-resistant bacterial infections, recently announced ...
An Australian study has linked rapidly growing mycobacterium infections to gastric banding surgery, but no clear source has been identified, according to an article published online September 10 in ...
Accurate detection is essential to prevent misdiagnosis and ensure the right treatment, particularly in cases involving drug-resistant TB or NTM infections. The Hi-PCR ® MTB/NTM Probe PCR Kit offers a ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired functionality—following the international gold standard for treating people with latent ...
NEW YORK — Two treatments that don't involve antibiotics have moved from the laboratory into clinical testing for control of nontuberculous mycobacteria (NTM) pulmonary disease, according to separate ...
Scientists from the University of Cape Town's (UCT) Institute of Infectious Disease and Molecular Medicine (IDM) have contributed to an international study that shed new light on why humans and ...
Mycobacteria are the world's most deadly bacteria --c ausing infectious diseases including tuberculosis (TB), which alone kills more than one million people each year. New drugs to fight these ...
Modified antibiotics beat a stubborn lung pathogen and dodge metabolic landmines, offering new hope for patients with HIV, cystic fibrosis, and TB co-infections. Study: Next-generation rifamycins for ...
Enormous progress has been made in tackling the global HIV epidemics over the past two decades. The number of people dying from HIV-related causes has fallen by 51% since 2010; and the number of ...